Z Squared ZSQR
NASDAQ ZSQR
$3.97 +0.02 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Z Squared (ZSQR) EBT Margin (2025 - 2026)

Updated

Z Squared's EBT Margin was -871.16% in Q2 2026, up 2663.04 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBT Margin was -798.69% through Jun 30, 2026, up 12341.27 percentage points year-over-year; for FY2025, it came in at -900.72%.

  • EBT Margin shows a four-year change of +17031.66 percentage points (FY2021 to FY2025).
  • In earlier years, EBT Margin was -17932.37% in FY2021.
  • Quarterly EBT Margin has moved between -5440.95% (Q1 2025) and -188.26% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBT Margin in the three quarters before Q2 2026 was -3534.20% (Q1 2026), -188.26% (Q4 2025) and -1220.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 26.66%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 25.18%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -4.11%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 29.63%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 18.19%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 27.53%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -131.41%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -4.34%
10 Z Squared 209.35 Mn 182.59 Mn -1.77 Mn -871.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.16%
Mar 31, 2026 -3,534.20%
Dec 31, 2025 -188.26%
Sep 30, 2025 -1,220.84%
Mar 31, 2025 -5,440.95%
API Access

Z Squared EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY